ERBB2 and breast cancer: BC is a heterogeneous disease that is classified into four major molecular subtypes: luminal A, luminal B, human epidermal growth factor receptor (HER2)-overexpressing, and basal-like, based on clinical, histopathological, and microarray criteria [3,4,5].